Radiolabeled peptides in diagnosis and tumor imaging: Clinical overview

This publication has 18 references indexed in Scilit:

• Whole-Body¹⁸F Dopa PET for Detection of Gastrointestinal Carcinoid Tumors
  Radiology, 2001
• Somatostatin Analogs for Cancer Treatment and Diagnosis: An Overview
  Chemotherapy, 2001
• Somatostatin Analogs in Oncology: A Look to the Future
  Chemotherapy, 2001
• Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
  Journal of Clinical Endocrinology & Metabolism, 2001
• Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours
  British Journal of Surgery, 2001
• Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment
  Current Opinion in Oncology, 2000
• Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals
  Seminars in Nuclear Medicine, 2000
• Somatostatin Receptors
  Digestion, 2000
• The Utility of a Somatostatin-Type Receptor Binding Peptide Radiopharmaceutical (P829) in the Evaluation of Solitary Pulmonary Nodules
  Chest, 1999
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993